Solasia Pharma K.K.
4597・Growth Market・Pharmaceuticals
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 5 directors (including 3 outside directors, an outside ratio of 60%), and the Board of Corporate Auditors is formed by 3 outside corporate auditors (all outside members). The Board of Directors met 13 times per year, with a high attendance rate among all directors. No nomination committee or compensation committee has been confirmed to be established.
Risk Management
The company has established Crisis Management Regulations with the President and Representative Director as the officer with ultimate responsibility, integrally monitoring and managing business risks, including sustainability-related risks, at the Board of Directors. Risk management is treated as a priority item in internal audits, with risk surveys conducted for each department at least once a year.
Shareholder Returns
No dividends continued as of the end of Q1 FY2026 (ending December 2026). The annual dividend forecast for FY2026 (ending December 2026) is ¥0. The company prioritizes upfront investment in pharmaceutical development, and its policy of considering dividends once commercialization results in a sufficiently sound financial position remains unchanged.
Dividend Policy
The annual dividend forecast for FY2026 (ending December 2026) is ¥0 (¥0 at Q2 end, ¥0 at year end). As business operations are weighted toward upfront investment in pharmaceutical development, the company is not currently in a financial position under the Companies Act to pay dividends, and thus remains dividend-free. Going forward, once the pharmaceuticals under development are commercialized and the company achieves a sufficiently sound financial position, it will consider dividends with an emphasis on balancing further development investment and shareholder returns.
ESG
Sustainability-related risks and opportunities are managed by the Board of Directors in an integrated manner with business risks. As part of its human capital strategy, the company has adopted a policy of securing and developing diverse talent regardless of age or gender, and has established a flextime system and incentive programs; however, quantitative indicators and targets have not yet been set. The company does not currently recognize climate change and other sustainability issues as risks or opportunities of high materiality.
Last updated: March 24, 2026